Atul drops after US arm faces regulatory scrutiny over alleged duty evasion
CBP has initiated an investigation based on the suspicion that Chinese-origin 2,4-Dichlorophenoxyacetic Acid (2,4-D) and its derivatives were transhipped through India to the USA warranting higher AD and CVD. The investigation is initiated against Atul USA Inc to ascertain alleged evasion of AD and CVD on 2,4-D and its derivatives.
As an interim measure, CBP has suspended the liquidation of each unliquidated entry of such covered merchandise imported into the USA after August 11, 2026 or as permitted by law. CBP may also take additional measures necessary to protect the revenue of the United States.
The company has Prima facie denies the allegation. stating that the potential impact of the investigation remains uncertain at this stage. It has engaged US-based legal counsel to seek advice and guidance on the matter.
The company reported a 13.12% decline in consolidated net profit attributable to owners to Rs 155.72 crore in Q2 FY27 from Rs 179.24 crore in Q2 FY26. Revenue from operations increased 20.96% YoY to Rs 1,877.04 crore in the quarter ended 30 September 2026.
Atul is mainly in the business of life science chemicals and performance and other chemicals and caters to the needs of varied industries across the world such as adhesives, agriculture, animal feed, automobile, composites, construction, cosmetic, defense, dyestuff, electrical and electronics, flavor, food, footwear, fragrance, glass, home care, horticulture, hospitality, paint and coatings, paper, personal care, pharmaceutical, plastic, polymer, rubber, soap and detergent, sport and leisure, textile, tyre and wind energy.
Powered by Capital Market - Live News